The new center is focused on collaboration and innovation to help accelerate new treatments
ST. LOUIS, MO - Biomedical Systems, a 40-year-old family-owned leading clinical trial provider to Pharmaceutical, Medical Device, Biotech, and Contract Research Organizations (CROs) – has opened its new technology and research center in St. Louis near the company's global headquarters. The state-of-the-art 12,000-square-foot center houses more than 70 software developers, data technicians and business analysts. The center was designed to foster innovation and integration of new technology, in collaboration with customers, to improve efficiencies and ultimately help expedite pharmaceuticals and devices to patients. "For more than 40 years, our business has been driven by the exceptional service and value we provide to our clients, who we view as family members," said Ray Barrett, chairman, Biomedical Systems. "Our new technology and research center provides the tools, technology and collaborative space necessary to develop new systems to meet our clients' needs." The technology and research center with its global data management system enables the company to scale its fast-growing business while maintaining quality, as it continues to accommodate the implementation of additional clinical trials. "The new technology and research center is dedicated to creating new and efficient ways to partner with Pharmaceutical, Medical Device, Biotech, and CROs to develop innovative solutions aimed at reducing barriers in the collection of data in clinical trials," said Jim Ott, chief technology officer, Biomedical Systems. "We are committed to helping our customers accelerate the execution of clinical trials, while maintaining quality data."
About Biomedical Systems
Biomedical Systems is a premier global provider of centralized diagnostic services. Founded in 1975, Biomedical Systems has grown to be a leading clinical trial provider to Pharmaceutical, Medical Device, Biotech, and CROs. Its comprehensive clinical trial solutions include Cardiac Safety, Pulmonary Function, Imaging, eCOA, and Scientific Affairs. Biomedical Systems' corporate headquarters are located in St. Louis, Missouri. European headquarters are located in Brussels, Belgium with supporting offices in Japan, China and India, which are able to resupply equipment and materials to challenging areas around the world in a timely, cost effective manner. Its global, multi-lingual staff speaks 21 languages facilitating communication with international sponsors and sites delivering better quality data. With five strategically located offices spanning the globe, Biomedical Systems has managed thousands of clinical trials in over 95 countries and can offer services and support 24 hours a day. For more information, visit
http://www.biomedsys.com/
.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.